NCIt definition : An orally available, 6,7-disubstituted-4-anilinoquinoline-3-carbonitrile irreversible
inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity.
Neratinib binds to the HER-2 receptor irreversibly, thereby reducing autophosphorylation
in cells, apparently by targeting a cysteine residue in the ATP-binding pocket of
the receptor. Treatment of cells with this agent results in inhibition of downstream
signal transduction events and cell cycle regulatory pathways; arrest at the G1-S
(Gap 1/DNA synthesis)-phase transition of the cell division cycle; and ultimately
decreased cellular proliferation. Neratinib also inhibits the epidermal growth factor
receptor (EGFR) kinase and the proliferation of EGFR-dependent cells.;
UNII : JJH94R3PWB;
InChIKey : JWNPDZNEKVCWMY-VQHVLOKHSA-N;
CAS number : 698387-09-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 698387-09-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;